NO20080510L - Anvendelse av endoplasminfragment og derivater derav som biomarkor for colorektal adenom og/eller karsinom, samt testsystem og fremgangsmate for deteksjon - Google Patents

Anvendelse av endoplasminfragment og derivater derav som biomarkor for colorektal adenom og/eller karsinom, samt testsystem og fremgangsmate for deteksjon

Info

Publication number
NO20080510L
NO20080510L NO20080510A NO20080510A NO20080510L NO 20080510 L NO20080510 L NO 20080510L NO 20080510 A NO20080510 A NO 20080510A NO 20080510 A NO20080510 A NO 20080510A NO 20080510 L NO20080510 L NO 20080510L
Authority
NO
Norway
Prior art keywords
carcinoma
colorectal
colorectal adenoma
endoplasmin
well
Prior art date
Application number
NO20080510A
Other languages
English (en)
Norwegian (no)
Inventor
Hartmut Juhl
Kerstin David
Anne-Kristin Fentz
Original Assignee
Indivumed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indivumed Gmbh filed Critical Indivumed Gmbh
Publication of NO20080510L publication Critical patent/NO20080510L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
NO20080510A 2005-08-19 2008-01-28 Anvendelse av endoplasminfragment og derivater derav som biomarkor for colorektal adenom og/eller karsinom, samt testsystem og fremgangsmate for deteksjon NO20080510L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2005/009005 WO2007019875A1 (en) 2005-08-19 2005-08-19 Use of an endoplasmin fragment and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system

Publications (1)

Publication Number Publication Date
NO20080510L true NO20080510L (no) 2008-05-19

Family

ID=36087694

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080510A NO20080510L (no) 2005-08-19 2008-01-28 Anvendelse av endoplasminfragment og derivater derav som biomarkor for colorektal adenom og/eller karsinom, samt testsystem og fremgangsmate for deteksjon

Country Status (13)

Country Link
US (1) US8580489B2 (ko)
EP (1) EP1917530B1 (ko)
JP (1) JP4832519B2 (ko)
KR (1) KR101314959B1 (ko)
AT (1) ATE499612T1 (ko)
AU (1) AU2005335652A1 (ko)
BR (1) BRPI0520483A2 (ko)
CA (1) CA2617214C (ko)
DE (1) DE602005026587D1 (ko)
IL (1) IL189185A0 (ko)
MX (1) MX2008001818A (ko)
NO (1) NO20080510L (ko)
WO (1) WO2007019875A1 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2472264B1 (en) * 2007-02-27 2015-11-25 SentoClone International AB Multiplex detection of tumour cells using a panel of agents binding to extracellular markers
CN109584961A (zh) * 2018-12-03 2019-04-05 元码基因科技（北京）股份有限公司 基于二代测序技术检测血液微卫星不稳定的方法
CN110244047B (zh) * 2019-06-10 2023-11-03 广州市妇女儿童医疗中心 肺癌血清诊断标志物及其应用、肺癌相关可溶性蛋白的分离鉴定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10019967A1 (de) * 2000-04-20 2001-10-25 Fenning Biomed Gmbh Dr Antikörper gegen natives gp96, deren Herstellung und Verwendung
CN100437115C (zh) 2002-12-20 2008-11-26 霍夫曼-拉罗奇有限公司 烟酰胺n-甲基转移酶作为结肠直肠癌标志的用途
US8067152B2 (en) * 2006-02-27 2011-11-29 The Fred Hutchinson Cancer Research Center Liver cancer biomarkers

Also Published As

Publication number Publication date
CA2617214C (en) 2013-02-12
US8580489B2 (en) 2013-11-12
JP2009505080A (ja) 2009-02-05
US20100273668A1 (en) 2010-10-28
KR101314959B1 (ko) 2013-10-11
JP4832519B2 (ja) 2011-12-07
WO2007019875A1 (en) 2007-02-22
EP1917530A1 (en) 2008-05-07
MX2008001818A (es) 2008-04-09
IL189185A0 (en) 2008-06-05
KR20080036652A (ko) 2008-04-28
DE602005026587D1 (de) 2011-04-07
ATE499612T1 (de) 2011-03-15
CA2617214A1 (en) 2007-02-22
EP1917530B1 (en) 2011-02-23
AU2005335652A1 (en) 2007-02-22
BRPI0520483A2 (pt) 2009-11-10

Similar Documents

Publication Publication Date Title
NO20070598L (no) Anvendelse av transtyridin som en biomarkor for colorektal adenom og/eller karsinom, samt deteksjonmetode og testsytem
WO2018187496A8 (en) PLASMA PROTEIN PROFILING FOR THE EARLY PROGNOSIS OF LUNG CANCER
MX2008009592A (es) Metodos y composiciones para identificar pacientes con una probabilidad incrementada de tener cancer de ovario.
WO2008109075A3 (en) Biomarkers and methods for determining sensitivity to ctla-4 antagonists
WO2007035676A3 (en) Methods and materials for identifying the origin of a carcinoma of unknown primary origin
WO2008134526A3 (en) Glycoprotein profiling of bladder cancer
BRPI0807227A2 (pt) métodos e materiais para identificação da origem de um carcinoma de origem primária desconhecida
WO2017050939A3 (en) Method and array for diagnosing pancreatic cancer in an individual
WO2009073505A3 (en) Methods for processing tandem mass spectral data for protein sequence analysis
JP2020514689A5 (ko)
GB2494580A (en) Method for diagnosing lung cancer
WO2007126901A3 (en) Apparatus and method for predicting disease
NO20080510L (no) Anvendelse av endoplasminfragment og derivater derav som biomarkor for colorektal adenom og/eller karsinom, samt testsystem og fremgangsmate for deteksjon
NO20053276L (no) Fremgangsmate og hjelpemiddel for pavisning av mykoplasma.
WO2014044791A3 (en) Methods and kits for predicting the sensitivity of a subject to chemotherapy
WO2008028066A3 (en) Boris isoforms and methods of detecting and treating disease
WO2006019991A3 (en) Method and apparatus for multimodal detection
WO2019060915A3 (en) Multiplexed protein assay for the detection of mitochondrial protein signatures
DK1416278T3 (da) Fremgangsmåder til forbedret diagnosticering af dysplasier
WO2017156154A9 (en) Compositions for characterizing development of esophageal adenocarcinoma in patients and methods of use thereof
BRPI0514314A (pt) método para detecção de e discriminação entre adenoma colorretal e/ou carcinoma colorretal, método para monitoramento de desenvolvimento e/ou curso e/ou de tratamento de adenoma colorretal e/ou carcinoma colorretal, uso de c3a ou derivado do mesmo, sistema de teste, conjunto compreendendo moléculas, método para determinar se um composto é efetivo no tratamento do adenoma colorretal e/ou carcinoma colorretal
ZA200801176B (en) Use of an endoplasmin fragment and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma ; method for detection and test system
ES2530618T3 (es) Método para discriminar entre carcinoma pulmonar en fase temprana y avanzada
WO2011012832A3 (fr) Methode de diagnostic d'un cancer, de determination du risque thrombotique chez un individu atteint d'un cancer et de determination de la severite d'un cancer chez un individu

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application